Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!   Twitter
Follow us on Instagram!  Instagram 
Add us to your circle in Google+!

Google+ 

Subscribe to our channel on YouTube!  YouTube  


 

 

Bookmark and Share   Print  

2014 Press Releases

 

12/29/2014   FDA Approves Ivacaftor for People with R117H Mutation of Cystic Fibrosis
12/10/2014   Cystic Fibrosis Foundation Therapeutics Announces $15 Million Research Project with Shire for Development of Novel CF Treatment
11/19/2014   Cystic Fibrosis Foundation Royalty Sale Will Be Transformational for People with CF
11/05/2014   Vertex Submits New Drug Application to FDA for Potential Combination Drug for Most Common CF Mutation
10/22/2014   FDA Panel Recommends Approval of Ivacaftor for People with R117H Mutation of CF
07/31/2014   Vertex Announces Phase 2 Results of Combination Treatment in People with One Copy of the F508del CF Mutation
06/24/2014   CFF Applauds Successful Phase 3 Results of Ivacaftor (Kalydeco) and Lumacaftor (VX-809) Drug Combination for People with Two Copies of F508del
05/15/2014   Across the Country, Great Strides are Underway to Find a Cure for Cystic Fibrosis
04/22/2014   Comedian Lewis Black & Friends Fight for a Cure for Cystic Fibrosis in Star-Studded Evening
03/04/2014   Cystic Fibrosis Foundation Therapeutics Extends Drug Development Collaboration with Proteostasis Therapeutics
02/21/2014   FDA Approves Expanded Use of Kalydecoâ„¢ for Eight Additional Mutations that Cause CF
02/11/2014   Expert Panel to Brief Congress on Innovative Models for Advancing Personalized Medicine and Improving High-Quality, Coordinated Care for Rare Diseases

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.